alfuzosin has been researched along with phenylpropanolamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Jung, SW; Lee, JW; Park, SC; Rim, JS | 1 |
| Kattan, MW; Nickel, JC; Shoskes, DA | 1 |
| Burckart, GJ; Green, DJ; Hirsch, M; Karesh, A; Khurana, M; Kim, MJ; Lee, J; Momper, JD; Mulugeta, Y; Sachs, HC; Yao, L | 1 |
1 trial(s) available for alfuzosin and phenylpropanolamine
| Article | Year |
|---|---|
The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Demography; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Postoperative Complications; Quinazolines; Stents; Surveys and Questionnaires; Tolterodine Tartrate; Young Adult | 2009 |
3 other study(ies) available for alfuzosin and phenylpropanolamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Cohort Studies; Cresols; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Pelvic Pain; Phenotype; Phenylpropanolamine; Probability; Prospective Studies; Prostatitis; Quinazolines; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Young Adult | 2010 |
Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study design.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Area Under Curve; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Humans; Infant; Mandelic Acids; Marine Toxins; Muscarinic Antagonists; Oxocins; Phenylpropanolamine; Quinazolines; Tablets; Tolterodine Tartrate; Urinary Bladder, Neurogenic | 2014 |